Added to YB: 2026-04-21
Pitch date: 2026-04-18
HIMS [bullish]
Hims & Hers Health, Inc.
+8.67%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$6.6B
Pitch Price
$28.54
Price Target
40.00 (+29%)
Dividend
N/A
EV/EBITDA
37.60
P/E
56.26
EV/Sales
3.03
Sector
Health Care Providers and Services
Category
special_situation
Why $HIMS?
HIMS (added to position): Peptides unlocking as RFK Jr. signals removal of 12 from FDA Category 2 restricted list. Only scaled telehealth w/ in-house peptide manufacturing. Novo Nordisk dropped lawsuit & partnered to distribute Wegovy/Ozempic via platform. Trading 20x fwd EV/EBITDA vs 30x fair value = $40 PT. Potential takeover target.
Read full article (7 min)